Isocarboxazid
Drug ingredientActive ShortageCAS 59-63-2
This drug ingredient is in active FDA shortage. At least one manufacturer cannot meet demand.
This chemical is not on EPA’s Toxic Substances Control Act inventory, the list behind EPA’s production survey.
Why supply is unknownProduction is reported production, not a complete census of factories. Import value and source-country shares describe a shared customs category, not a separate chemical measurement.
Where It Comes From
Customs basis: HS 293499 · basket
These shares come from HS customs code 293499, which covers 575 tracked chemicals in total. They estimate the category's origin mix, not this chemical specifically.
- Finland
- Netherlands
- Canada
- Indonesia
- Mexico
- Taiwan
- South Korea
- Austria
- Croatia
- Sweden
- Ukraine
- Denmark
- Israel
- Czech Republic
- New Zealand
- Hong Kong
- Kyrgyzstan
- Australia
- Portugal
- South Africa
- Poland
- Slovenia
- Brazil
- Slovakia
- Vietnam
- Latvia
- Malta
- Hungary
- Romania
- Kenya
- Belarus
- Russia
- Turkey
- Norway
1 FDA-registered drug labeler
Why It Matters
- Current shortage
Isocarboxazid Tablet
Shortage listed since April 16, 2026
Manufacturer reports: 1 unavailable
Vendor Pricing
Prices reflect listed pack sizes. Small research packs run far above bulk rates.
12 more vendors
| Vendor | Country Supplier country. Where available, shows shipping origin. When the supplier ships from a different country than where they are registered, both are shown. Most suppliers show registration country only. | $/g | Pack | Purity |
|---|---|---|---|---|
| TargetMol Chemicals | China → United States | $1766.00 | 500 mg | 99.94% |
| Aaron Chemicals LLC | Hong Kong | $2256.00 | 500 mg | 95% |
| Angene Chemical | China → Hong Kong | $2270.00 | 500 mg | 95% |
| A2B Chem LLC | United States | $2950.00 | 100 mg | 99.94% |
| AA BLOCKS | United States | $3270.00 | 100 mg | 98% |
| Combi-Blocks (back-ordered) | United States | $3820.00 | 250 mg | 95% |
| TargetMol Chemicals EU | Austria | $3890.00 | 100 mg | 99.94% |
| Cayman Europe | Estonia | $4688.60 | 100 mg | 98% |
| MedChemExpress MCE | Sweden | $7865.00 | 50 mg | 98.94% |
| Angene International Limited | United States | $11360.00 | 50 mg | 98% |
| MedKoo Biosciences, Inc | United States | $18000.00 | 25 mg | 98% |
| AstaTech (2 weeks) | United States | $23800.00 | 5 mg | 95% |
Chemical Identity
Data Sources
- PubChem · compound 3759Retrieved 2026-04-07
- FDA National Drug Code directoryRetrieved 2026-04-25
- FDA Drug ShortagesRetrieved 2026-10-04
- US Census international tradeReporting year: 2024 · Retrieved 2026-10-04
Brief citations
Isocarboxazid (CAS 59-63-2) https://chemicalindependence.com/chemical/59-63-2/ PubChem: 3759. Retrieved 2026-04-07. https://pubchem.ncbi.nlm.nih.gov/compound/3759 FDA National Drug Code directory: CAS 59-63-2. Retrieved 2026-04-25. https://open.fda.gov/data/ndc/ FDA Drug Shortages: CAS 59-63-2. Retrieved 2026-10-04. https://www.accessdata.fda.gov/scripts/drugshortages/ US Census international trade: HS 293499 for CAS 59-63-2. Reporting year: 2024. https://usatrade.census.gov/